BCI
GSK icon

Brinker Capital Investments’s GSK GSK Stock Holding History

Brinker Capital Investments’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.44M Buy
122,948
+2,421
+2% +$128K 0.05% 324
2026
Q1 		$6.65M Sell
120,527
-15,398
-11% -$834K 0.06% 302
2025
Q4 		$6.67M Buy
135,925
+10,940
+9% +$510K 0.05% 338
2025
Q3 		$5.39M Buy
124,985
+4,527
+4% +$177K 0.04% 403
2025
Q2 		$4.63M Buy
120,458
+37,636
+45% +$1.44M 0.04% 422
2025
Q1 		$3.21M Buy
82,822
+61,735
+293% +$2.26M 0.03% 500
2024
Q4 		$713K Buy
21,087
+3,581
+20% +$129K 0.01% 1213
2024
Q3 		$716K Buy
17,506
+114
+0.7% +$4.66K 0.01% 1191
2024
Q2 		$670K Buy
17,392
+795
+5% +$33.4K 0.01% 1168
2024
Q1 		$712K Buy
16,597
+252
+2% +$10.4K 0.01% 1131
2023
Q4 		$648K Sell
16,345
-1,486
-8% -$53.3K 0.01% 1114
2023
Q3 		$646K Buy
17,831
+411
+2% +$14.6K 0.01% 1103
2023
Q2 		$621K Buy
17,420
+3,722
+27% +$134K 0.01% 1141
2023
Q1 		$487K Buy
13,698
+5,845
+74% +$204K 0.01% 1152
2022
Q4 		$276K Buy
7,853
+653
+9% +$21.8K 0.01% 1180
2022
Q3 		$212K Sell
7,200
-912
-11% -$34.6K ﹤0.01% 1261
2022
Q2 		$441K Sell
8,112
-42,603
-84% -$2.35M 0.01% 1022
2022
Q1 		$2.76M Buy
50,715
+1,505
+3% +$81.7K 0.04% 409
2021
Q4 		$2.71M Buy
49,210
+3,843
+8% +$200K 0.04% 456
2021
Q3 		$2.26M Hold
45,367
– – 0.04% 517
2021
Q2 		$2.26M Buy
45,367
+12,651
+39% +$608K 0.03% 570
2021
Q1 		$1.47M Sell
32,716
-12,442
-28% -$565K 0.02% 585
2020
Q4 		$2.08M Buy
45,158
+21,692
+92% +$996K 0.03% 548
2020
Q3 		$1.11M Buy
+23,466
New +$1.18M 0.02% 655
2019
Q3 		– Sell
-659
Closed -$33K – 833
2019
Q2 		$33K Buy
659
+198
+43% +$9.94K ﹤0.01% 640
2019
Q1 		$24K Buy
+461
New +$23K ﹤0.01% 531
2017
Q3 		– Sell
-4,942
Closed -$266K – 586
2017
Q2 		$266K Sell
4,942
-607
-11% -$32.4K 0.01% 267
2017
Q1 		$292K Buy
5,549
+1,115
+25% +$56.6K 0.01% 256
2016
Q4 		$213K Buy
4,434
+486
+12% +$24K 0.01% 259
2016
Q3 		$213K Buy
+3,948
New +$216K 0.01% 253
2014
Q4 		– Sell
-2,813
Closed -$162K – 432
2014
Q3 		$162K Buy
+2,813
New +$172K 0.01% 251
2014
Q2 		– Sell
-2,410
Closed -$161K – 388
2014
Q1 		$161K Sell
2,410
-533
-18% -$36K 0.01% 265
2013
Q4 		$196K Buy
2,943
+57
+2% +$3.7K 0.01% 261
2013
Q3 		$181K Buy
2,886
+76
+3% +$4.89K 0.01% 261
2013
Q2 		$175K Buy
+2,810
New +$178K 0.01% 264

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Brinker Capital Investments's GSK Position: Q2 2026 in Review

Brinker Capital Investments increased its GSK (GSK) stake by 2% in Q2 2026, buying an estimated $128K and bringing the position to 122,948 shares worth $6.44M. The position accounts for 0.05% of the portfolio, ranked #324.

Brinker Capital Investments first reported a position in GSK in Q2 2013 and has held it in 35 quarters since. The position peaked at $6.67M in Q4 2025. 1,037 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • Brinker Capital Investments held 122,948 shares of GSK worth $6.44M as of Q2 2026.
  • Brinker Capital Investments bought 2,421 GSK shares in Q2 2026, an estimated $128K.
  • GSK made up 0.05% of Brinker Capital Investments's portfolio in Q2 2026, its #324 holding.
  • Brinker Capital Investments first reported a position in GSK in Q2 2013 and has held it in 35 quarters since.
  • Brinker Capital Investments's GSK position peaked at $6.67M in Q4 2025.
  • 1,037 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Brinker Capital Investments's 13F filing for Q2 2026, filed 14 Aug 2026.